Drugmaker Imprimis Pharma To Market Cheaper Alternative To Retrophin Kidney Stone Drug Thiola Imprimis Pharmaceuticals is in it again. The company plans to produce a cheaper alternative to the already FDA-approved Thiola by Retrophin. by Angela Laguipo
Healthy Living/Wellness US Senate Panel To Investigate Valeant, Turing Drug Price Hike by Katherine Derla